Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Yin, Yong1 | Yang, Keke1 | Li, Juanjuan | Da, Peng | Zhang, Zhenxin | Qiu, Xiaoxia*
Affiliations: Department of Otorhinolaryngology – Head and Neck Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China
Correspondence: [*] Corresponding author: Xiaoxia Qiu, Department of Otorhinolaryngology – Head and Neck Surgery, Affiliated Hospital of Nantong University, 20 XiSi Road, Chongchuan, Nantong, Jiangsu, 226001, China. Tel.: +86 513 81161021; E-mail: [email protected].
Note: [1] These authors contributed equally to the work.
Abstract: OBJECTIVE: To assess the expression levels of IFITM1 in human tissue samples and laryngeal squamous cell carcinoma (LSCC) cells, and to explore the potential mechanisms of IFITM1 in LSCC progression. METHODS: Quantitative PCR and immunohistochemical (IHC) assays were performed to detect IFITM1 expression in 62 LSCC tissues and corresponding normal tissues. We further detected the effects of IFITM1 on the proliferation, migration and invasion of LSCC cells and NF-κB signaling pathway through colony formation assay, wound healing assay and transwell assay, respectively. RESULTS: We demonstrated the possible involvement of IFITM1 in the progression of LSCC. We found the upregulated expression of IFITM1 in human LSCC tissues and cells, and analyzed the correlations between IFITM1 expression and osteopontin. Our data further confirmed that IFITM1 affected cell proliferation, migration, and invasion of LSCC cells via the regulation of NF-κB signaling pathway. CONCLUSIONS: We investigated the potential involvement of IFITM1 in the progression of LSCC, and therefore confirmed that IFITM1 was a potential therapeutic target for LSCC.
Keywords: Laryngeal squamous cell carcinoma, interferon-induced transmembrane protein 1 (IFITM1), proliferation, migration, osteopontin, NF-κB signaling pathway, therapeutic target
DOI: 10.3233/CBM-201435
Journal: Cancer Biomarkers, vol. 29, no. 4, pp. 521-529, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]